Richard Paulson | President, Chief Executive Officer |
Sohanya Cheng | Chief Commercial Officer |
Jatin Shah | Chief Medical Officer |
Michael Mason | Chief Financial Officer |
Sarah Connors | Vice President, Corporate Communications |
Maury Raycroft | Jefferies |
Peter Lawson | Barclays |
Mike Ulz | Morgan Stanley |
Steve | RBC Capital Markets |
Eric Joseph | JP Morgan |
Jonathan Chang | SVB Leerink |
Ed White | HC Wainwright |
Arlinda Lee | Canaccord |
Good morning. My name is Sara and I will be your conference Operator today. At this time, I would like to welcome everyone to the Karyopharm Therapeutics fourth quarter and full year 2021 financial results conference call. There will be a question and answer session to follow. Please be advised that this call is being recorded at the company’s request.